Fucoxanthin regulates Nrf2 signaling to decrease oxidative stress and improves renal fibrosis depending on Sirt1 in

Guanyu Yang1, Qingde Li2, Jing Peng2

  • 1Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou, 570228, China.

Insights

Fucoxanthin, a marine carotenoid, improves diabetic kidney disease by activating Sirt1/Nrf2 signaling, reducing oxidative stress and renal fibrosis in diabetic rats.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Diabetic nephropathy (DN) is a severe complication of diabetes, characterized by oxidative stress.
  • Nuclear factor erythroid 2-related factor 2 (Nrf2) and Silent information regulator T1 (Sirt1) are key regulators of cellular defense against oxidative stress.

Purpose of the Study:

  • To investigate if fucoxanthin alleviates diabetic nephropathy by activating Sirt1/Nrf2 signaling.
  • To explore the potential of fucoxanthin as a therapeutic agent for diabetic kidney disease.

Main Methods:

  • Streptozotocin-induced diabetic rat model and high glucose-cultured rat glomerular mesangial cells.
  • Assessment of renal function, glomerulosclerosis, protein levels of Sirt1 and Nrf2, and activity of antioxidant enzymes.
  • Utilized Sirt1 inhibitor (EX527) to confirm the role of Sirt1.

Main Results:

  • Fucoxanthin treatment improved renal function and reduced glomerulosclerosis in diabetic rats.
  • Fucoxanthin increased Sirt1 and Nrf2 protein levels in kidneys and mesangial cells.
  • Fucoxanthin enhanced the expression and activity of superoxide dismutase and heme oxygenase 1, dependent on Sirt1 activation.

Conclusions:

  • Fucoxanthin ameliorates diabetic nephropathy by activating Sirt1/Nrf2 signaling pathway.
  • This activation leads to reduced oxidative stress and renal fibrosis, suggesting therapeutic potential for diabetic kidney disease.